Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist
M A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry
|
June 10, 2011
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophrenia
Christopher J Helal, Zhijun Kang, Xinjun Hou, et al.
Journal of Medicinal Chemistry
|
September 29, 2017
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging
Lei Zhang, Laigao Chen, Elizabeth M Beck, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1)
Sean T Murphy, Gordon Alton, Simon Bailey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2022
First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, et al.
Journal of Medicinal Chemistry
|
June 3, 2017
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Christopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry
|
April 7, 2018
Correction to Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Christopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry
|
January 3, 2018
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
Christopher J Helal, Eric Arnold, Tracey Boyden, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist
M A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry
|
June 10, 2011
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophrenia
Christopher J Helal, Zhijun Kang, Xinjun Hou, et al.
Journal of Medicinal Chemistry
|
September 29, 2017
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging
Lei Zhang, Laigao Chen, Elizabeth M Beck, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1)
Sean T Murphy, Gordon Alton, Simon Bailey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2022
First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, et al.
Journal of Medicinal Chemistry
|
June 3, 2017
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Christopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry
|
April 7, 2018
Correction to Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Christopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry
|
January 3, 2018
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
Christopher J Helal, Eric Arnold, Tracey Boyden, et al.
Page
of 2